UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6359) 6359
Book Chapter (65) 65
Newsletter (50) 50
Newspaper Article (27) 27
Magazine Article (22) 22
Conference Proceeding (2) 2
Dissertation (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (5888) 5888
humans (4930) 4930
science & technology (4654) 4654
life sciences & biomedicine (4567) 4567
female (2912) 2912
male (2876) 2876
antibodies, monoclonal - therapeutic use (2437) 2437
adult (2307) 2307
middle aged (2108) 2108
tumor necrosis factor-alpha - antagonists & inhibitors (1818) 1818
treatment outcome (1766) 1766
antibodies, monoclonal - administration & dosage (1432) 1432
gastroenterology & hepatology (1272) 1272
etanercept (1239) 1239
adalimumab (1224) 1224
antibodies, monoclonal - adverse effects (1213) 1213
rheumatology (1187) 1187
biological and medical sciences (1175) 1175
medical sciences (1174) 1174
rheumatoid arthritis (1066) 1066
aged (1061) 1061
crohn disease - drug therapy (1043) 1043
arthritis, rheumatoid - drug therapy (1019) 1019
monoclonal antibodies (941) 941
antirheumatic agents - therapeutic use (886) 886
crohn's disease (886) 886
drug therapy (882) 882
care and treatment (821) 821
inflammatory bowel disease (717) 717
dosage and administration (704) 704
tumor necrosis factor-α (699) 699
adolescent (691) 691
ulcerative colitis (678) 678
retrospective studies (666) 666
pharmacology & pharmacy (658) 658
infliximab - therapeutic use (637) 637
dermatology (630) 630
abridged index medicus (627) 627
medicine & public health (626) 626
young adult (625) 625
pharmacology. drug treatments (620) 620
drug therapy, combination (613) 613
patients (602) 602
psoriasis (581) 581
severity of illness index (578) 578
gastrointestinal agents - therapeutic use (556) 556
anti-inflammatory agents - therapeutic use (551) 551
tumor necrosis factor (531) 531
antirheumatic agents - administration & dosage (523) 523
follow-up studies (522) 522
tumor necrosis factor-tnf (520) 520
immunoglobulin g - therapeutic use (503) 503
receptors, tumor necrosis factor - therapeutic use (491) 491
immunosuppressive agents - therapeutic use (488) 488
antirheumatic agents - adverse effects (483) 483
immunology (482) 482
colitis, ulcerative - drug therapy (480) 480
time factors (473) 473
drug administration schedule (471) 471
research (462) 462
risk factors (455) 455
infliximab - administration & dosage (453) 453
arthritis (447) 447
gastrointestinal agents - administration & dosage (415) 415
antibodies, monoclonal, humanized (411) 411
analysis (409) 409
psoriasis - drug therapy (403) 403
tumor necrosis factor-alpha - immunology (399) 399
inflammatory bowel diseases - drug therapy (392) 392
prospective studies (392) 392
child (384) 384
animals (382) 382
diseases of the osteoarticular system (372) 372
methotrexate (369) 369
anti-inflammatory agents - administration & dosage (368) 368
dose-response relationship, drug (368) 368
health aspects (364) 364
remission induction (362) 362
infusions, intravenous (361) 361
general & internal medicine (334) 334
immunomodulators (327) 327
methotrexate - therapeutic use (323) 323
internal medicine (321) 321
medicine, general & internal (318) 318
inflammation (316) 316
antibodies, monoclonal, humanized - therapeutic use (314) 314
inflammatory bowel diseases (307) 307
inflammatory joint diseases (307) 307
clinical trials (301) 301
antibodies, monoclonal - pharmacology (297) 297
gastroenterology. liver. pancreas. abdomen (293) 293
gastrointestinal agents - adverse effects (284) 284
complications and side effects (281) 281
infliximab - adverse effects (279) 279
other diseases. semiology (272) 272
gastroenterology (268) 268
anti-inflammatory agents, non-steroidal - therapeutic use (267) 267
rheumatoid factor (264) 264
stomach. duodenum. small intestine. colon. rectum. anus (264) 264
anti-inflammatory agents - adverse effects (258) 258
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6246) 6246
Japanese (80) 80
Spanish (80) 80
German (66) 66
French (55) 55
Russian (52) 52
Italian (26) 26
Portuguese (21) 21
Hungarian (17) 17
Korean (13) 13
Danish (10) 10
Chinese (6) 6
Polish (6) 6
Norwegian (3) 3
Turkish (3) 3
Hebrew (2) 2
Croatian (1) 1
Dutch (1) 1
Greek (1) 1
Icelandic (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of allergy and clinical immunology, ISSN 0091-6749, 10/2020, Volume 146, Issue 4, pp. 786 - 789
COVID-19 | adverse drug reactions | SARS-CoV-2 | drug allergy | coronavirus | Acute respiratory syndrome | remdesivir | drug hypersensitivity | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Betacoronavirus - pathogenicity | Interleukin 1 Receptor Antagonist Protein - administration & dosage | Pandemics | Alanine - adverse effects | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Pyrazines - administration & dosage | Drug Hypersensitivity - drug therapy | Adrenal Cortex Hormones - therapeutic use | Indoles - administration & dosage | Infliximab - administration & dosage | Betacoronavirus - immunology | Alanine - analogs & derivatives | Infliximab - adverse effects | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Amides - adverse effects | Drug Hypersensitivity - diagnosis | Pyrazoles - adverse effects | Drug Hypersensitivity - etiology | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Cytokine Release Syndrome - immunology | Cytokine Release Syndrome - virology | Immunity, Innate - drug effects | Cytokine Release Syndrome - prevention & control | Betacoronavirus - drug effects | Immunologic Factors - administration & dosage | Antiviral Agents - administration & dosage | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Adenosine Monophosphate - adverse effects | Pyrazoles - administration & dosage | Indoles - adverse effects | Coronavirus Infections - virology | Drug Hypersensitivity - immunology | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Pyrazines - adverse effects | Interleukin 1 Receptor Antagonist Protein - adverse effects | Immunologic Factors - adverse effects | Amides - administration & dosage | Pneumonia, Viral - virology | Drugs | Stevens-Johnson syndrome | Disease | Exanthema | Chloroquine | Herpes simplex | Viruses | Interleukin 6 | Vesicles | Cell activation | Anaphylaxis | Infliximab | Cefditoren | Peptidyl-dipeptidase A | Interleukin 1 | Varicella | Lesions | Chronic illnesses | Cytokines | Urticaria | Interleukin 1 receptor antagonist | Hypersensitivity | Inflammation | RNA polymerase | Coronaviruses | Eosinophilia | Patients | Severe acute respiratory syndrome coronavirus 2 | Hydroxychloroquine | Respiratory distress syndrome | Purpura | γ-Interferon | Angiotensin | Monoclonal antibodies | Erythema | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10006, pp. 1825 - 1834
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2008, Volume 134, Issue 7, pp. 1861 - 1868
Journal Article
Journal Article